Home Medical Devices Global Minimally Invasive Gastrointestinal Surgical Systems Market Size, Demand to 2032

Minimally Invasive Gastrointestinal Surgical Systems Market

Minimally Invasive Gastrointestinal Surgical Systems Market Size, Share & Trends Analysis Report By Product Type (Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS), Surgical Robotics, Others), By Surgery (Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon and Rectal Surgery, Foregut Surgery, Hernia Repair), By End-Users (Conventional Technologies, Surgical Robotics) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRMD1936DR
Study Period 2020-2032 CAGR 6.43%
Historical Period 2020-2022 Forecast Period 2024-2032
Base Year 2023 Base Year Market Size USD 6.23 billion
Forecast Year 2032 Forecast Year Market Size USD 11.71 billion
Largest Market North America Fastest Growing Market
The sample report only takes 30 secs to download, no need to wait longer.

Market Overview

The global minimally invasive gastrointestinal surgical systems market size was valued at USD 6.23 billion in 2023. It is estimated to reach USD 11.71 billion by 2032, growing at a CAGR of 6.43% during the forecast period (2024–2032). In recent years, several factors have contributed to the expansion of the market for minimally invasive gastrointestinal surgical systems. These factors include the advantages of minimally invasive surgeries in comparison to traditional open surgeries, the growing demand for minimally invasive procedures, the development of advanced surgical systems, the rise in healthcare expenditures, the expansion of healthcare outcomes, public-private initiatives that support research on minimally invasive surgical instruments, and the expansion of healthcare infrastructure.

Highlights

  1. Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) dominate the product type segment.
  2. Hernia Repair dominates the surgery segment.
  3. North America is the highest shareholder in the global market

Market Overview

Minimally invasive gastrointestinal surgery encompasses a range of surgical techniques designed to minimize tissue damage, expedite recovery, and reduce postoperative complications compared to traditional open surgery. This approach includes laparoscopic surgery, robotic-assisted surgery, and natural orifice transluminal endoscopic surgery (NOTES), all of which aim to achieve surgical goals with less impact on the body. Intelligent robotic systems and smaller, more advanced tools are becoming increasingly common as surgical technology develops. 

By reducing costs, enhancing patient outcomes, and opening up the possibility of minimally invasive surgery to a wider spectrum of physicians, these advances have the potential to completely change the healthcare industry. A high-definition video camera shows the operative field on an operating room screen during laparoscopic surgery, giving the operator better visibility and illumination. In order to put ports through which the camera and surgical tools are introduced, the surgeon must create multiple tiny incisions in the abdomen. It has been demonstrated that this method lessens discomfort, speeds up recovery, and lowers the chance of wound problems like infections, hernias, and excessive scar tissue creation.

Market Dynamics

Global Minimally Invasive Gastrointestinal Surgical Systems Market Drivers

Increasingly Popular as an Alternative to More Conventional Open Surgeries

The global market for minimally invasive gastrointestinal surgical systems is experiencing robust growth, primarily driven by an increasing preference for minimally invasive procedures over traditional open surgeries. This shift is due to the various benefits these techniques offer, including reduced postoperative pain, faster recovery times, shorter hospital stays, and lower risks of complications such as infections and hernias. As patients become more aware of these advantages, demand for minimally invasive surgical options has surged, prompting healthcare providers to embrace these techniques. Moreover, healthcare providers recognize the dual benefits of minimally invasive surgery, i.e., improved patient outcomes and cost reductions. This recognition has led to a significant shift in how surgical procedures are performed, with a growing emphasis on adopting advanced surgical systems that minimize tissue damage and expedite recovery. As a result, the global market for minimally invasive gastrointestinal surgical systems is experiencing notable expansion.

Beyond the gastrointestinal field, minimally invasive surgery plays a critical role in other areas of medicine, with varying degrees of precision and error tolerance required depending on the specific procedure. For example, spinal surgery demands accuracy within 2 millimeters to prevent damage to the spinal cord, with error rates expected to be below 3% to avoid significant postoperative complications. Brain surgery necessitates even higher precision, with movement accuracy required to be within 1 millimeter and error rates ideally lower than 2%. In ophthalmic surgery, precision is paramount, with accuracy limits often less than 0.5 millimeters and error rates below 1% to prevent corneal damage and ensure successful outcomes. These stringent requirements in other surgical fields demonstrate the critical importance of precision in minimally invasive procedures.

Global Minimally Invasive Gastrointestinal Surgical Systems Market Restraint

Shortage of Skilled Professionals

The global market for minimally invasive gastrointestinal surgical systems faces a significant challenge: a shortage of skilled professionals with the expertise to perform these complex procedures. Minimally invasive surgeries, such as laparoscopy and robotic-assisted surgery, require specialized training and a high level of technical skill, which can limit the widespread adoption of these advanced techniques. This shortage of skilled professionals poses risks to both patient outcomes and the market's growth potential.

Moreover, the impact of this skills gap is multi-faceted. With fewer trained professionals, healthcare facilities may experience longer procedure times, increased risks of complications, and less-than-ideal surgical outcomes. These factors can undermine the benefits typically associated with minimally invasive surgery, such as shorter recovery times and lower risk of infections. Healthcare providers might find it difficult to meet patient demand for these treatments if there is a shortage of qualified surgeons, which could result in longer wait times and less access to care.

Global Minimally Invasive Gastrointestinal Surgical Systems Market Opportunities

Technological Advancements

The global minimally invasive gastrointestinal surgical systems market is poised for growth, fueled by rapid technological advancements transforming the surgical landscape. One of the key drivers of this market growth is the continuous improvement in surgical robotics. These robotic systems offer unparalleled precision, allowing surgeons to perform complex gastrointestinal procedures with greater accuracy and control. The introduction of smaller, more flexible robotic instruments enables surgeons to access hard-to-reach areas with minimal disruption to surrounding tissues. For instance, The Cleveland Clinic is the first hospital in the country to use a recently FDA-approved surgery robot with magnetic technology to perform a minimally invasive gastric sleeve treatment.

Sleeve gastrectomy, another name for gastric sleeve surgery, is one of the popular bariatric surgical techniques. It leaves behind a narrow "sleeve" after removing a significant amount of the stomach. Another significant advancement is the development of artificial intelligence (AI) and machine learning (ML) in minimally invasive surgery. These technologies have the potential to assist surgeons in real-time decision-making, improving the accuracy of procedures and reducing the risk of errors. AI-driven predictive analytics can also aid in preoperative planning, enabling more effective and customized surgical approaches for each patient.

Regional Analysis

Based on region, the global minimally invasive gastrointestinal surgical systems market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. 

North America Dominates the Global Market

North America is the most significant global minimally invasive gastrointestinal surgical systems market shareholder and is expected to expand substantially during the forecast period. This dominance can be ascribed to several factors, including the high adoption rate of minimally invasive surgery devices, rising healthcare costs, and improved healthcare outcomes across the region. Similarly, the strong presence of major market players such as Medtronic, Stryker, and Johnson & Johnson Services, Inc., among others, significantly boosts the region's market stability and growth. In North America, the increasing acceptance of technology in the healthcare industry, combined with the growing demand for minimally invasive procedures, presents substantial opportunities for manufacturers. This has encouraged companies to expand their services and secure a strong position in the industry. Healthcare providers and health insurance companies are using more digital health tools to improve the effectiveness, accessibility, and quality of care, according to the 2023 ISG Provider LensTM Healthcare Digital Services report for the United States. Organizations are keeping a closer eye on patients, expediting provider data exchange, and providing patients with tailored wellness information by utilizing patient-facing apps and integrated electronic health records (EHRs). Moreover, North America's robust healthcare infrastructure and well-established regulatory framework support the continuous development and integration of minimally invasive technologies.

The Asia-Pacific region is projected to be the fastest-growing segment in the global minimally invasive gastrointestinal surgical systems market. This rapid growth is propelled by the rising prevalence of gastrointestinal disorders and an expanding elderly population, both of which contribute to the demand for healthcare services, including minimally invasive gastrointestinal procedures. Another key driver of growth in Asia-Pacific is the increasing awareness of the benefits of minimally invasive procedures. As patients and healthcare providers in the region become more informed about the reduced pain, quicker recovery times, and lower risk of complications associated with minimally invasive surgery, demand for these procedures is expected to surge. This trend, coupled with the large and growing population, provides a substantial market base for minimally invasive surgical systems.

Report Scope

Report Metric Details
Segmentations
By Product Type
  1. Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)
  2. Surgical Robotics
  3. Others
By Surgery
  1. Adrenalectomy
  2. Appendectomy
  3. Bariatric Surgery
  4. Cholecystectomy
  5. Colon and Rectal Surgery
  6. Foregut Surgery
  7. Hernia Repair
By End-Users
  1. Conventional Technologies
  2. Surgical Robotics
Company Profiles B. Braun Melsungen AG Conmed Corporation Karl Storz SE & Co. KG Medtronic plc Olympus Corporation Stryker Corporation TransEnterix, Inc. Boston Scientific Corporation Cook Medical, Inc. Richard Wolf GmbH Intuitive Surgical, Inc. Ambu A/S Sch•lly Fiber Optic GmbH Xenocor, Inc. Fujifilm Holdings Corporation Pentax Medical (Hoya Corporation)
Geographies Covered
North America U.S. Canada
Europe U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
APAC China Korea Japan India Australia Singapore Taiwan South East Asia Rest of Asia-Pacific
Middle East and Africa UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
LATAM Brazil Mexico Argentina Chile Colombia Rest of LATAM
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Segmental Analysis

The global minimally invasive gastrointestinal surgical systems market is bifurcated into product type, surgery, and end-user.

Based on product type, the global minimally invasive gastrointestinal surgical systems market is segmented into Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS), surgical robotics, and others.

The conventional MISS segment dominates the global market. Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) are surgical procedures that involve small incisions. As a result, patients experience less trauma, have a shorter recovery time, and spend less time in the hospital than they would during traditional open surgeries. Endoscopes, video scopes, endoscopy ultrasounds, therapeutic energy devices, and point-of-sale systems are all the components that make up these systems. Conventional minimally invasive gastrointestinal surgical systems (MISS) minimize postoperative pain, speed up healing, and lower the risk of complications, including hernias and infections. These advantages have increased demand for minimally invasive operations, which has caused a shift in surgical preferences in favor of less invasive techniques. Patients visit hospitals more frequently to receive treatment for gastrointestinal disorders due to their increased awareness of these advantages.

Based on surgery, the global minimally invasive gastrointestinal surgical systems market is segmented into adrenalectomy, appendectomy, bariatric surgery, cholecystectomy, colon and rectal surgery, foregut surgery, and hernia repair.

Hernia repair dominates the surgery segment. This procedure addresses hernias, which are bulges or tears in the abdominal wall or diaphragm that can cause pain and other complications. Minimally invasive hernia repair offers several advantages over traditional open surgery, making it the preferred approach for many patients and healthcare providers. The minimally invasive hernia repair benefits are reduced postoperative pain, shorter recovery times, fewer hospital stays, and a low risk of complications such as infections, blood loss, and secondary hernias. These advantages contribute to improved patient satisfaction and quicker returns to normal activities. As a result, the demand for minimally invasive hernia repair has surged, leading to a noticeable shift in surgical preferences towards less invasive methods.

Based on end-users, the global minimally invasive gastrointestinal surgical systems market is bifurcated into conventional technologies and surgical robotics.

Surgical robotics is increasingly becoming a key end-user in the global market. As healthcare providers seek more precise and less invasive techniques for gastrointestinal procedures, robotic-assisted surgery has gained prominence due to its numerous advantages, both for surgeons and patients. Robotic surgical systems offer unparalleled precision, flexibility, and control, enabling surgeons to perform complex, minimally invasive gastrointestinal procedures with heightened accuracy. This technology allows for a level of skill surpassing traditional laparoscopic surgery, allowing surgeons to easily navigate complex anatomical structures. As a result, procedures can be performed through smaller incisions, leading to less tissue trauma, reduced postoperative pain, and faster recovery times.

Market Size By Product Type

Recent Developments

  • December 2023- A USD 42 million C-1 preferred financing round was successfully closed, according to EndoQuest Robotics, Inc. (the "Company"), a privately held medical device firm and a trailblazing leader in the development of cutting-edge endoluminal robotic technologies. This innovative, flexible endoluminal robot will be developed further thanks to this critical investment to revolutionize minimally invasive operations.

Top Key Players

B. Braun Melsungen AG Conmed Corporation Karl Storz SE & Co. KG Medtronic plc Olympus Corporation Stryker Corporation TransEnterix, Inc. Boston Scientific Corporation Cook Medical, Inc. Richard Wolf GmbH Intuitive Surgical, Inc. Ambu A/S Sch•lly Fiber Optic GmbH Xenocor, Inc. Fujifilm Holdings Corporation Pentax Medical (Hoya Corporation) Others

Frequently Asked Questions (FAQs)

How big is the minimally invasive gastrointestinal surgical systems market?
The global minimally invasive gastrointestinal surgical systems market size was valued at USD 6.23 billion in 2023. It is estimated to reach USD 11.71 billion by 2032, growing at a CAGR of 6.43% from 2024 to 2032.
Asia Pacific region has the highest growth rate in the minimally invasive gastrointestinal surgical systems market.
Increasingly popular as an alternative to more conventional open surgeries is the major growth factor of the minimally invasive gastrointestinal surgical systems market.
Conventional MISS market sector is expected to dominate over the forecast period.
The key players in the global minimally invasive gastrointestinal surgical systems market include B. Braun Melsungen AG, Conmed Corporation, Karl Storz SE & Co. KG, Medtronic plc, Olympus Corporation, Stryker Corporation, TransEnterix, Inc., Ambu A/S, Xenocor, Inc., Fujifilm Holdings Corporation, Pentax Medical (Hoya Corporation).


We are featured on :